{
  "id": 5313,
  "text": "J Clin Oncol 2000;18:1606-1613.Available at: http://www.ncbi.nlm.nih.gov/pubmed/10764420.132.Whitney CW, Sause W, Bundy BN, et al.Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: J Clin Oncol 2000;18:1606-1613.Available at: http://www.ncbi.nlm.nih.gov/pubmed/10764420.132.Whitney CW, Sause W, Bundy BN, et al.Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "在治疗IIB-IVA期宫颈癌且腹主动脉旁淋巴结阴性患者时，研究表明与羟基脲辅助放疗相比，氟尿嘧啶联合顺铂作为辅助放疗可能具有更好的效果。这些化疗药物与放疗联用后，能够提高治疗的有效性，改善患者的总体生存率和疾病控制率。通过这种联合治疗，可以更有效地抑制癌症的进展，为患者提供更好的预后。这一疗法的应用得到了专业研究的支持，能够为患者提供更有力的治疗选择。",
  "query": "在IIB-IVA期宫颈癌且腹主动脉旁淋巴结阴性患者的治疗中，与羟基脲辅助放疗相比，氟尿嘧啶联合顺铂作为辅助放疗的效果如何？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在IIB-IVA期宫颈癌且腹主动脉旁淋巴结阴性患者的治疗中，与羟基脲辅助放疗相比，氟尿嘧啶联合顺铂作为辅助放疗的效果如何？\n\n<reference text>: J Clin Oncol 2000;18:1606-1613.Available at: http://www.ncbi.nlm.nih.gov/pubmed/10764420.132.Whitney CW, Sause W, Bundy BN, et al.Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "在治疗IIB-IVA期宫颈癌且腹主动脉旁淋巴结阴性患者时，研究表明与羟基脲辅助放疗相比，氟尿嘧啶联合顺铂作为辅助放疗可能具有更好的效果。这些化疗药物与放疗联用后，能够提高治疗的有效性，改善患者的总体生存率和疾病控制率。通过这种联合治疗，可以更有效地抑制癌症的进展，为患者提供更好的预后。这一疗法的应用得到了专业研究的支持，能够为患者提供更有力的治疗选择。"
}